Early Onset Neonatal E.Coli Sepsis
dc.contributor.author | O’Rahelly, M. | |
dc.contributor.author | Smith, A. | |
dc.contributor.author | Drew, R. | |
dc.contributor.author | McCallion, N. | |
dc.date.accessioned | 2019-03-01T12:27:15Z | |
dc.date.available | 2019-03-01T12:27:15Z | |
dc.date.issued | 2019-02 | |
dc.identifier.uri | http://hdl.handle.net/10147/624110 | |
dc.description.abstract | Neonatal sepsis is a major cause of neonatal morbidity and mortality in term and preterm infants. The timely identification of infants at risk of infection is of particular importance in the vulnerable preterm group1 and is a major focus of microbiological research in the Rotunda Hospital. E.coli accounts for approximately 14.1% of early onset sepsis, i.e. sepsis before 72 hours of age in our centre. E.coli is the second most common pathogen, along with coagulase negative Staphylococcus, after group B Streptococcus (GBS)2. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Irish Medical Journal | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | SEPSIS | en_US |
dc.subject | SEPTICEMIA | en_US |
dc.subject | NEONATES | en_US |
dc.subject.other | E COLI | en_US |
dc.title | Early Onset Neonatal E.Coli Sepsis | en_US |
dc.type | Article | en_US |
dc.identifier.journal | Irish Medical Journal | en_US |
dc.description.funding | No funding | en_US |
dc.description.province | Leinster | en_US |
dc.description.peer-review | peer-review | en_US |
refterms.dateFOA | 2019-03-01T12:27:15Z |